Skip to main content
GutCited

Complementary and alternative medications in the management of inflammatory bowel disease.

Sherman Picardo, Mansour Altuwaijri, Shane M Devlin, Cynthia H Seow
Review Therapeutic advances in gastroenterology 2020 21 인용
PubMed DOI
<\/script>\n
`; }, get iframeSnippet() { const domain = 'gutcited.com'; const params = 'pmid\u003D32523629'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

Study Design

연구 유형
Review
대상 집단
IBD patients
중재
Complementary and alternative medications in the management of inflammatory bowel disease. None
대조군
Conventional treatment
일차 결과
None
효과 방향
Mixed
비뚤림 위험
Unclear

Abstract

The use of complementary and alternative medications (CAM), products, and therapies not considered to be part of conventional medicine is common among patients with inflammatory bowel disease (IBD). Patients often turn to these therapies as they are considered natural and safe, with significant benefit reported beyond disease control. There is emerging evidence that some of these therapies may have anti-inflammatory activity; however, robust evidence for their efficacy in modulating disease activity is currently lacking. Patients often avoid discussing the use of CAM with their physicians, which may lead to drug interactions and/or reduced adherence with conventional therapy. It is important for physicians to be aware of the commonly used CAM and current evidence behind these therapies in order to better counsel their patients about their use in the management of IBD. This narrative review provides an overview of the evidence of the more commonly used CAM in patients with IBD.

요약

An overview of the commonly used CAM and current evidence behind these therapies in patients with IBD is provided in order to better counsel their patients about their use in the management of IBD.

Used In Evidence Reviews

Similar Papers